GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹243 Cr | ₹269 Cr | ₹320 Cr | ₹3.82 Cr | ₹3.93 Cr |
What is the latest Total Debt ratio of GLAND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹243 Cr |
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹3.82 Cr |
| Mar2022 | ₹3.93 Cr |
How is Total Debt of GLAND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹243 Cr | -9.60 | |
| Mar2025 | ₹269 Cr | -15.81 | |
| Mar2024 | ₹320 Cr | 8,269.07 | |
| Mar2023 | ₹3.82 Cr | -2.85 | |
| Mar2022 | ₹3.93 Cr | - | |
Compare Total Debt of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,594.8 Cr | 3.5% | 5.6% | 61.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.5% |
5.6% |
61.5% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses